Showing results (1331-1340 of 2,482) with videos related to
Sort By:
Pageof 249
Clinical and Translational Science|August 28, 2023
Co-consuming green tea with raloxifene decreases raloxifene systemic exposure in healthy adult participantsJohn D Clarke, Sabrina M Judson, Dan-Dan Tian, et al.Clinical and Translational Science|August 8, 2023
A randomized, controlled single, and multiple ascending dose trial of the safety, pharmacokinetics and pharmacodynamics of SN1011 in healthy subjectsLeilei Zhu, Rong Shi, Tongfang Zhao, et al.Clinical and Translational Science|August 3, 2023
Areas of strength and opportunities for growth in translational science education and training: Results of a scoping review from the NCATS Education BranchAmanda L Vogel, Brittany M Haynes, Shadab F Hussain, et al.Clinical and Translational Science|August 2, 2023
Plasma lipidomic analysis to investigate putative biomarkers of P-glycoprotein activity in healthy volunteersThéodore Decaix, Romain Magny, Isabelle Gouin-Thibaut, et al.Clinical and Translational Science|August 1, 2023
Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumorsGatot Nyarumenteng Adhipurnawan Winarno, Jusuf Sulaeman Effendi, Ali Budi Harsono, et al.Clinical and Translational Science|August 22, 2023
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of ART-001 with a novel oral pediatric formulation in healthy subjectsAkira Tanaka, Naoto Uemura, Kanako Kuniyeda, et al.Clinical and Translational Science|August 19, 2023
A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteersNicholas S Jones, Smita Kshirsagar, Vishnu Mohanan, et al.Clinical and Translational Science|August 21, 2023
Study protocol: A comparison of mobile and clinic-based spirometry for capturing the treatment effect in moderate asthmaElena S Izmailova, Rachel Kilian, Jessie P Bakker, et al.Clinical and Translational Science|October 18, 2023
Rademikibart (CBP-201), a next-generation monoclonal antibody targeting human IL-4Rα: Two phase I randomized trials, in healthy individuals and patients with atopic dermatitisJunying Wang, Jeffery White, Kenneth J Sansone, et al.Clinical and Translational Science|October 27, 2023
Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register dataPaloma Moraga Alapont, Paula Prieto, Mikel Urroz, et al.Pageof 249